PHYCOLOGICAL RESEARCH is a leading journal in the field of aquatic and plant sciences, published by Wiley, recognized for its commitment to advancing knowledge in the study of algae and their ecological significance. With a diverse scope encompassing ecological interactions, evolutionary behaviors, and physiological processes, PHYCOLOGICAL RESEARCH aims to provide a platform for researchers to disseminate innovative findings and insights pertinent to both agricultural and biological sciences. The journal's impressive rankings—placing it in the 74th percentile within Agricultural and Biological Sciences (miscellaneous) and holding a Q2 category in key fields—underscore its impact and importance in academia. Despite not being open access, the journal ensures broad distribution and visibility through its dedicated readership. Since its inception in 1995, PHYCOLOGICAL RESEARCH has continuously evolved, shaping and influencing the direction of research in phycology and related disciplines, making it an essential resource for students, professionals, and researchers alike.

Cancer & Metabolism is a distinguished open-access journal published by BMC, dedicated to advancing the understanding of the complex interactions between cancer biology and metabolic processes. Since its inception in 2013, it has provided a platform for researchers, clinicians, and students to disseminate groundbreaking research and innovative findings within the fields of oncology and metabolism. The journal, identified by its E-ISSN 2049-3002, is recognized for contributing valuable insights into metabolic alterations that influence cancer progression, treatment responses, and overall patient outcomes. With a firm commitment to open access, Cancer & Metabolism ensures that research is freely available to the global scientific community, fostering collaboration and accelerating discoveries that can lead to improved therapeutic strategies. As a vital resource in cancer research, this journal appeals to a broad audience, including researchers looking to share their latest findings, professionals seeking to stay informed on cutting-edge developments, and students eager to delve into the relationship between metabolism and cancer.

Nature Metabolism, published by NATURE PORTFOLIO, is a leading journal dedicated to advancing the field of metabolic research and its implications across various biological systems. Since its inception in 2019, this esteemed journal has rapidly established itself as a vital resource for researchers, professionals, and students alike, reflecting its prominence through a prestigious Q1 ranking in several key categories including Cell Biology, Endocrinology, Diabetes and Metabolism, Internal Medicine, and Physiology. With an impressive Scopus ranking, underscoring its impact in Medicine and Biochemistry disciplines, Nature Metabolism offers an exceptional platform for disseminating high-quality research that explores the intricate mechanisms of metabolism and its association with health and disease. Although currently not open access, it continues to gain visibility and appreciation within the scientific community, ensuring that groundbreaking findings reach interested audiences globally from its hub in Berlin, Germany. Whether you are an experienced researcher or an aspiring student, Nature Metabolism serves as an invaluable asset in navigating the complexities of metabolic science.

EUROPEAN JOURNAL OF LIPID SCIENCE AND TECHNOLOGY, published by WILEY, is a reputable academic journal dedicated to advancing the field of lipid science and technology. With an ISSN of 1438-7697 and E-ISSN 1438-9312, this journal serves as a critical resource for researchers, professionals, and students interested in the bioengineering, industrial applications, and nutritional science of lipids. Covering a broad spectrum from biochemistry to food science, it holds distinguished rankings across multiple categories, including Q2 in Chemistry and Food Science, and Q3 in Biotechnology, showcasing its significance in the interdisciplinary study of lipids. The journal welcomes Open Access options, fostering the dissemination of knowledge and innovation in lipid research. With converged years extending from 2000 to 2024, this journal remains at the forefront of lipid-related research, encouraging scholarly contributions that push the boundaries of science and technology.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, published by Elsevier, is a leading academic journal that focuses on advancing the field of lipid biology. With an ISSN of 1388-1981 and an E-ISSN of 1879-2618, this journal has established itself as an essential resource for researchers, professionals, and students interested in cell and molecular biology, particularly regarding lipid interactions and functions. The journal boasts an impressive impact factor, standing in the top quartiles of its categories—Q1 in Molecular Biology and Q2 in Cell Biology. As part of the vibrant academic landscape of the Netherlands, it supports both traditional and open access publication models, ensuring that vital research is accessible to a global audience. The converged years from 1998 to 2025 mark its sustained commitment to quality and relevance in the fast-evolving field of lipid research. With a strong ranking in Scopus and a percentile in the 80th range in both Molecular Biology and Cell Biology, this journal continues to be a pivotal platform for scholarly communication and innovation in lipid-related research.

BIOCHEMICAL JOURNAL, published by Portland Press Ltd, stands as a leading publication in the fields of Biochemistry, Cell Biology, and Molecular Biology, reflecting a commitment to advancing scientific knowledge since its inception in 1945. With a distinguished Q1 ranking across these categories and impressive Scopus rankings, the journal serves as an invaluable resource for researchers, professionals, and students alike, facilitating critical discoveries and innovative research practices. Although not currently offering open access, the journal provides a platform for high-quality peer-reviewed articles, ensuring rigorous standards in the dissemination of biochemical research. Spanning over seven decades and continuing through to 2024, the BIOCHEMICAL JOURNAL fosters an environment where cutting-edge biochemical research thrives, supporting the global scientific community's efforts to address complex biological questions and enhance our understanding of fundamental cellular processes.

AAPS PHARMSCITECH is a prestigious peer-reviewed journal published by Springer, focusing on the dynamic field of pharmaceutical sciences and technology. With an ISSN of 1530-9932, it provides a vital platform for disseminating cutting-edge research that spans key areas including drug discovery, pharmacology, toxicology, and ecological impacts of pharmaceuticals. The journal is recognized for its rigorous scientific contributions, currently holding a commendable Q2 quartile ranking across several relevant categories, including Agronomy and Crop Science, Aquatic Science, and Medicine in 2023. Notably, it ranks 43rd out of 183 in the Scopus Pharmacology, Toxicology, and Pharmaceutics category, placing it in the 76th percentile of its field. Aiming to foster innovation and collaboration among researchers, professionals, and students, AAPS PHARMSCITECH is committed to advancing scientific knowledge and addressing contemporary challenges in pharmaceutical sciences. The journal offers various access options to ensure wide dissemination of research findings, making it an essential resource for those dedicated to enhancing public health through pharmaceutical advancements.

Molecular Therapy Nucleic Acids is a premier open-access journal published by CELL PRESS, dedicated to advancing the field of molecular medicine through the innovative application of nucleic acid-based therapies. Since its inception in 2012, this journal has become an essential resource for researchers and professionals in drug discovery and molecular medicine, reflected in its status as a Q1 journal in both categories for 2023. With a notable impact factor and high rankings in Scopus, including #8 out of 157 in Drug Discovery and #16 out of 178 in Molecular Medicine, it serves to disseminate groundbreaking research and foster collaborations among scientists worldwide. The journal's comprehensive scope encompasses a wide variety of topics, including gene therapy, RNA interference, and CRISPR technology, ensuring that it remains at the forefront of scientific excellence. With open access availability, Molecular Therapy Nucleic Acids actively promotes the widespread dissemination of knowledge, making its crucial insights accessible to students, researchers, and industry professionals alike.

Welcome to the Journal of Membrane Biology, a premier publication dedicated to advancing our understanding of the complex roles membranes play in biological systems. Published by Springer, this journal features research articles, reviews, and communications on a broad range of topics related to membrane biology, including biomolecular interactions, transport mechanisms, and physiological responses. With an ISSN of 0022-2631 and E-ISSN 1432-1424, the journal has been a cornerstone in the field since its inception in 1969 and continues to thrive as it looks towards 2024. Ranked in the second quartile (Q2) for Biophysics and Physiology, and third quartile (Q3) in Cell Biology, it showcases impactful research that embodies the spirit of scientific inquiry and innovation. Although currently not an Open Access journal, it remains easily accessible to researchers, professionals, and students eager to delve into the dynamic world of membrane studies. As the understanding of membrane dynamics expands, so does its relevance in areas such as drug development and cellular engineering, making the Journal of Membrane Biology an essential resource for those at the forefront of these critical scientific advancements.

DRUG DELIVERY is a premier academic journal published by TAYLOR & FRANCIS LTD, with a steadfast commitment to advancing research in the fields of medicine and pharmaceutical sciences. As an Open Access journal since 2017, it offers unparalleled accessibility to its high-quality content, making it an invaluable resource for researchers, professionals, and students alike. With an impressive 2023 impact factor, it ranks in the Q1 quartile for both Medicine (miscellaneous) and Pharmaceutical Science, evidencing its significant impact within the scientific community. The journal focuses on innovative drug delivery systems, therapeutics, and methodologies that enhance patient care and treatment options. Based in the United Kingdom, it has evolved since its inception in 1993 to create a richly diverse platform for scholarly dialogue and advancements in the pharmaceutical landscape. Researchers looking to stay at the forefront of drug delivery research will find DRUG DELIVERY an essential companion in their pursuits.